noom glp 1 microdosing expands its GLP-1 range with 'microdose' package GLP-1 Microdosing Reshapes Weight Loss

Imcivree (setmelanotide): EPAR - product information

In 2022, GLP-1 RAs became available as weight management drugs

Small-molecule GLP-1RA litigation over the coming decade will likely generate more numerous, more independently contested patent challenges than peptide GLP-1RA litigation has

This discovery led to the development of exenatide, which in 2005 became the first GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes (T2DM)

For patients with T2DM

For adults without contraindications, the standard evidence-based protein recommendation is .8 grams per kilogram of body weight per day, or about .36 grams per pound , to supply standard bodily functions, including the maintenance of muscle mass and hair